In­ovio agrees to shell out $44M to set­tle Covid-19 vac­cine law­suit

Three months af­ter bring­ing on a new CEO, In­ovio has reached a set­tle­ment with in­vestors over ac­cu­sa­tions that it ex­ag­ger­at­ed progress on its Covid-19 vac­cine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER